Last $52.13 USD
Change Today +0.09 / 0.17%
Volume 306.4K
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Frankfurt
OTC US
OTC US
OTC US
As of 8:10 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitleKey Developments
Stephen Sabba M.D. 11 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeLigand Announces SEC Investigation
09/12/05
David Knott 26 RelationshipsDirector, Member of Audit Committee and Member of Compensation CommitteeLigand Pharmaceuticals Inc. announced delayed 10-Q filing
11/9/06
Sunil Patel 8 RelationshipsDirector and Member of Audit CommitteeLigand Pharmaceuticals Inc. announced delayed annual 10-K filing
03/16/06

Compensation Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitle
Jason Aryeh 21 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Todd Davis 19 RelationshipsDirector and Chairman of Compensation Committee
David Knott 26 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
John LaMattina Ph.D. 80 RelationshipsDirector and Member of Compensation Committee
LGND Compensation vs. Industry
500.3K
361.5K
Chief Executive Officer
294.6K
266.2K
Chief Financial Officer
368.1K
346.3K
Chief Operating Officer
Share price activity for LIGAND PHARMACEUTICALS (LGND)
52 Week Price Performance
LGND
Industry Average

Nominating Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitleKey Developments
John Kozarich Ph.D. 50 RelationshipsChairman and Member of Nominating & Corporate Governance CommitteeLigand Pharmaceuticals Incorporated Names Melanie J. Herman as Principal Accounting Officer
04/11/14
Jason Aryeh 21 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeLigand Pharmaceuticals Incorporated Announces Management Changes
02/11/14
Stephen Sabba M.D. 11 RelationshipsDirector, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeSyed Kazmi to Leave Ligand Pharmaceuticals Incorporated as Vice President, Business Development and Strategic Planning, Effective August 31, 2012
05/4/12

Corporate Governance Committee* - ligand pharmaceuticals (LGND)

Name (Connections)Board RelationshipsTitle
Jason Aryeh 21 RelationshipsIndependent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
John Kozarich Ph.D. 50 RelationshipsDirector and Chairman of Compensation Committee
Stephen Sabba M.D. 11 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
LGND and Competitor
Insiders vs. External
Board
11%
89%
Ligand Pharmaceuticals Incorporated
Insiders
External Board Members

Advisory Committee* - ligand pharmaceuticals (LGND)

Name (Board Relationships)/Title Board Affiliations
Shalendar Bhasin 8 Relationships
Scientific Advisor
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $52.13 USD +0.09

LGND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LGND.
View Industry Companies
 

Industry Analysis

LGND

Industry Average

Valuation LGND Industry Range
Price/Earnings 100.0x
Price/Sales 18.9x
Price/Book 23.6x
Price/Cash Flow 149.5x
TEV/Sales 11.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.